| Code | 0613F | ||||||||||
| MA number | 18/0253/25-S | ||||||||||
| Product Form: | tbl flm 30x1x5 mg (blis.oPA/Al/PVC//Al - jednotk.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 02.08.2025 |
| Validity: | 02.08.2030 |
| SPC: |
SPC_Jeligo_tbl flm_07/2025_REG.pdf
|
| PIL: |
PIL_Jeligo_tbl flm_07/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 04.08.2025 |
